These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

474 related items for PubMed ID: 8901600

  • 1. Blockade of T-cell costimulation prevents development of experimental chronic renal allograft rejection.
    Azuma H, Chandraker A, Nadeau K, Hancock WW, Carpenter CB, Tilney NL, Sayegh MH.
    Proc Natl Acad Sci U S A; 1996 Oct 29; 93(22):12439-44. PubMed ID: 8901600
    [Abstract] [Full Text] [Related]

  • 2. Late blockade of T cell costimulation interrupts progression of experimental chronic allograft rejection.
    Chandraker A, Azuma H, Nadeau K, Carpenter CB, Tilney NL, Hancock WW, Sayegh MH.
    J Clin Invest; 1998 Jun 01; 101(11):2309-18. PubMed ID: 9616202
    [Abstract] [Full Text] [Related]

  • 3. Chronic cardiac rejection in the LEW to F344 rat model. Blockade of CD28-B7 costimulation by CTLA4Ig modulates T cell and macrophage activation and attenuates arteriosclerosis.
    Russell ME, Hancock WW, Akalin E, Wallace AF, Glysing-Jensen T, Willett TA, Sayegh MH.
    J Clin Invest; 1996 Feb 01; 97(3):833-8. PubMed ID: 8609241
    [Abstract] [Full Text] [Related]

  • 4. T-cell costimulatory blockade in experimental chronic cardiac allograft rejection: effects of cyclosporine and donor antigen.
    Chandraker A, Russell ME, Glysing-Jensen T, Willett TA, Sayegh MH.
    Transplantation; 1997 Apr 27; 63(8):1053-8. PubMed ID: 9133464
    [Abstract] [Full Text] [Related]

  • 5. CD28-B7-mediated T cell costimulation in chronic cardiac allograft rejection: differential role of B7-1 in initiation versus progression of graft arteriosclerosis.
    Kim KS, Denton MD, Chandraker A, Knoflach A, Milord R, Waaga AM, Turka LA, Russell ME, Peach R, Sayegh MH.
    Am J Pathol; 2001 Mar 27; 158(3):977-86. PubMed ID: 11238045
    [Abstract] [Full Text] [Related]

  • 6. CD28-B7 T cell costimulatory blockade by CTLA4Ig in the rat renal allograft model: inhibition of cell-mediated and humoral immune responses in vivo.
    Akalin E, Chandraker A, Russell ME, Turka LA, Hancock WW, Sayegh MH.
    Transplantation; 1996 Dec 27; 62(12):1942-5. PubMed ID: 8990393
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Toward novel antirejection strategies: in vivo immunosuppressive properties of CTLA4Ig.
    Perico N, Imberti O, Bontempelli M, Remuzzi G.
    Kidney Int; 1995 Jan 27; 47(1):241-6. PubMed ID: 7731152
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. CD28-B7 T-cell co-stimulatory blockade potentiates the effects of intrathymic immunomodulation in sensitized graft recipients.
    Stadlbauer TH, Schaub M, Korom S, Onodera K, Sayegh MH, Kupiec-Weglinski JW.
    Transplantation; 1997 Dec 27; 64(12):1816-22. PubMed ID: 9422425
    [Abstract] [Full Text] [Related]

  • 14. Blockade of multiple costimulatory receptors induces hyporesponsiveness: inhibition of CD2 plus CD28 pathways.
    Woodward JE, Qin L, Chavin KD, Lin J, Tono T, Ding Y, Linsley PS, Bromberg JS, Baliga P.
    Transplantation; 1996 Oct 15; 62(7):1011-8. PubMed ID: 8878397
    [Abstract] [Full Text] [Related]

  • 15. Blockade of CD28/B7-2 costimulation inhibits experimental obliterative bronchiolitis in rat tracheal allografts: suppression of helper T cell type1-dominated immune response.
    Tikkanen JM, Lemström KB, Koskinen PK.
    Am J Respir Crit Care Med; 2002 Mar 01; 165(5):724-9. PubMed ID: 11874822
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Soluble CTLA4Ig modifies parameters of acute inflammation in rat lung allograft rejection without altering lymphocytic infiltration or transcription of key cytokines.
    Matsumura Y, Zuo XJ, Prehn J, Linsley PS, Marchevsky A, Kass RM, Matloff JM, Jordan SC.
    Transplantation; 1995 Feb 27; 59(4):551-8. PubMed ID: 7533346
    [Abstract] [Full Text] [Related]

  • 20. CTLA4Ig alone or in combination with low-dose cyclosporine fails to reverse acute rejection of renal allograft in the rat.
    Perico N, Amuchastegui S, Bontempelli M, Remuzzi G.
    Transplantation; 1996 May 15; 61(9):1320-2. PubMed ID: 8629290
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.